Completed NCT00999895
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Pátrai Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Observational i A study where researchers collect information without assigning a treatment. From 18 Years to 65 Years
Countries Greece
Sponsor AstraZeneca
Condition Schizophrenia Completed NCT00520923
This study is completed in Argentina, in Austria, in Croatia, .... It focuses on schizophrenia.
Multiple locations, including Banfield Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 65 Years
Countries Argentina, Austria, Croatia, ...
Sponsor Denovo Biopharma LLC
Condition Schizophrenia Terminated NCT01125358
This summary needs review. Please check the official study record and contact the research team for details.
Multiple locations, including Aichi Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 20 Years to 65 Years
Countries Japan, South Korea, Taiwan
Sponsor Denovo Biopharma LLC
Condition Schizophrenia Terminated NCT01077791
This study was terminated in France. It is testing remediation Program of Social Cognition for schizophrenia.
In Le Chesnay Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Behavioral From 18 Years to 57 Years
Countries France
Sponsor Assistance Publique - Hôpitaux de Paris
Condition Schizophrenia Completed NCT00300846
This study is completed in France, in the United Kingdom, in Switzerland, .... It is testing treatment of Aripiprazole for Schizophrenia.
Multiple locations, including Graz Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries France, United Kingdom, Switzerland, ...
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT00567203
This study is completed in the United States. It is testing treatment Of Cognitive Deficits for schizophrenia.
Multiple locations, including Glendale Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 55 Years
Countries United States
Sponsor Pfizer
Condition Schizophrenia Completed NCT02634346
This study is completed in the United States, in Bulgaria, in Serbia, .... It is testing ALKS 3831 for schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 70 Years
Countries United States, Bulgaria, Serbia, ...
Sponsor Alkermes, Inc.
Condition Schizophrenia Completed NCT01903837
This study is completed in the United States, in Bulgaria, and in Czechia. It is testing ALKS 3831 for schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 50 Years
Countries United States, Bulgaria, Czechia
Sponsor Alkermes, Inc.
Condition Schizophrenia Completed NCT02694328
This study is completed in the United States. It is testing ALKS 3831 for schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 55 Years
Countries United States
Sponsor Alkermes, Inc.
Condition Schizophrenia Completed NCT01493726
This study is completed in the United States. It is testing ALKS 9072 for schizophrenia.
Multiple locations, including Atlanta Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 55 Years
Countries United States
Sponsor Alkermes, Inc.
Condition Schizophrenia Completed NCT00237939
This study is completed in France, in Belgium, in the Netherlands, .... It is testing aripiprazole for schizophrenia.
Multiple locations, including Antwerp Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries France, Belgium, Netherlands, ...
Sponsor Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition Schizophrenia Completed NCT02634320
This study is completed in the United States. It is testing aripiprazole Lauroxil (Also Known for schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States
Sponsor Alkermes, Inc.
Condition Schizophrenia